Chapter 3 Structural Changes in the Aged Brain

Advances in Cell Aging and Gerontology

Volumn 2, Issue C, 1997, Pages 51-76

  Dickson, Dennis W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007645406     PISSN: 15663124     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1566-3124(08)60053-X     Document Type: Article

References (114)

1. Akiyama H., and McGeer P.L. Brain microglia constitutively express β2 integrins. J. Neuroimmunol. 30 (1990) 81-93
2. Albert M. Neuropsychological and neurophysiological changes in healthy adult humans across the age range. Neurobiol. Aging 14 (1993) 623-625
3. Arai H., Lee V.M., Otvos Jr. L., Greenberg B.D., Lowery D.E., Sharma S.K., Schmidt M.L., and Trojanowski J.Q. Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc. Natl. Acad. Sci. USA 87 (1990) 2249-2253
4. Arriagada P.V., Marzloff K., and Hyman B.T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer' s disease. Neurology 42 (1992) 1681-1688
5. Beach T.G., Walker R., and McGeer E.G. Patterns of gliosis in Alzheimer's disease and aging cerebrum. GLIA 2 (1989) 420-436
6. Beyreuther K., and Masters C.L. Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function. Brain Pathol. 1 (1991) 241-251
7. Birren J.E. Age changes in speed of behavior: its central nature and physiological correlates. In: Welford A.T., and Birren J.E. (Eds). Behavior, Aging and the Nervous System (1971), Charles C. Thomas, Springfield, IL. 191-216
8. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
9. Braak H., Braak E., Grundke-Iqbal I., and Iqbal K. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci. Lett. 65 (1986) 351-355
10. Braak H., Duyckaerts C., Braak E., and Piette F. Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Nicolini M., Zatta P.F., and Corain B. (Eds). Alzheimer's Disease: Advances in Clinical and Basic Research (1993), John Wiley & Sons, New York 131-138
11. Crystal H.A., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Grober E., Masdeu J., Kawas C., Aronson M., and Wolfson L. Clinico-pathological studies in dementia: Non-demented subjects with pathologically confirmed Alzheimer's disease. Neurology 38 (1988) 1682-1687
12. Crystal H.A., Dickson D., Sliwinski M., Masur D., Blau A., and Lipton R.D. Associations of status and change measures of neuropsychological function with pathological changes in elderly, originally nondemented subjects. Arch. Neurol. 53 (1996) 82-87
13. Crystal H.A., Dickson D.W., Sliwinski M., Lipton R., Grober E., Marks-Nelson H., and Antis P. Pathological markers associated with normal aging and dementia in the elderly. Ann. Neurol. 34 (1993) 566-573
14. Davies L., Molska B., Hilbich C., Multhaup G., Martins R., Simms G., Beyreuther K., and Masters C.L. A4 amyloid deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology. 38 (1988) 1688-1693
15. Delaere P., Duyckaerts C., Brion J.P., Poulain V., and Hauw J.J. Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol. 77 (1989) 645-653
16. Delaere P., Duyckaerts C., Masters C., Beyreuther K., Piette F., and Hauw J.J. Large amounts of neocortical β/A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci. Lett. 116 (1990) 87-93
17. Delaere P., He Y., Fayet G., Duyckaerts C., and Hauw J.J. Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiol. Aging 14 (1993) 191-194
18. Dickson D.W. Neuropathology of normal aging. In: Markesbery W. (Ed). Neuropathology of Dementing Disorders (1997), Edward Arnold Publishers, London in press
19. Dickson D.W. Pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56 (1997) 321-339
20. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A., Davies P., Yen S.-H., and Aronson M.K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13 (1992) 1-11
21. Dickson D.W., Farlo J., Davies P., Crystal H., Fuld P., and Yen S.-H. Alzheimer's disease: A double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 132 (1988) 86-101
22. Dickson D.W., Frucht S.J., Crystal H.A., and Koo E.H. Quantitative analysis of β-amyloid in pathological aging: levels of amyloid comparable to those in Alzheimer's disease. Neurology 44 Suppl 2 (1994) A387
23. Dickson D.W., Ivanushkin A., Heitner J., Yen S.-H., and Davies P. Apolipoprotein-E immunoreactivity is increased in deposits of Alzheimer's disease, but not pathological aging or diffuse Lewy body disease. In: Iqbal H., Mortimer J.A., Winblad B., and Wisniewski H.M. (Eds). Research Advances in Alzheimer's Disease and Related Disorders (1995), John Wiley & Sons, New York 371-383
24. Dickson D.W., and Lee S.C. Microglia. In: Davis R.L., and Robertson D.M. (Eds). Textbook of Neuropathology. 3rd edition (1996), Williams & Wilkins, Baltimore 165-205
25. Dickson D.W., Singer G., Davies P., Yen S.-H., and Crystal H.A. Regional immunocytochemical studies of brains of prospectively studied demented and nondemented elderly humans. In: Nicolini M., Zatta P.F., and Corain B. (Eds). Alzheimer's disease: Advances in Clinical and Basic Research (1993), John Wiley & Sons, New York 123-126
26. Dickson D.W., Sinicropi S., Yen S.-H., Ko L.-W., Mattiace L.A., Bucala R., and Vlassara H. Glycation and microglial reaction in lesions of Alzheimer's disease. Neurobiol. Aging 17 (1996) 733-743
27. Dickson D.W., Wertkin A., Kress Y., Ksiezak-Reding H., and Yen S.-H. Ubiquitin-immunoreactive structures in normal brains: distribution and developmental aspects. Lab. Invest. 63 (1990) 87-99
28. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., and Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382 (1996) 716-719
29. Eng L.F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8 (1985) 203-214
30. Giannakopoulos P., Hof P.R., Giannakopoulos A.-S., Herrman F.R., Michel J.-P., and Bouras C. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch. Neurol. 52 (1995) 1150-1159
31. Gibson P.H. Ultrastructural abnormalities in the cerebral neocortex and hippocampus associated with Alzheimer's disease and aging. Acta Neuropathol. 73 (1987) 86-91
32. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., and Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulfated glycosaminoglycans. Nature 383 (1996) 550-553
33. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., and Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. USA 85 (1988) 4051-4055
34. Gowing E., Roher A.E., Woods A.S., Cotter R.J., Chaney M., Little S.P., and Ball M.J. Chemical characterization of the Aβ17--42 peptide, a component of diffuse amyloid deposits of Alzheimer's disease. J. Biol. Chem. 269 (1994) 10987-10990
35. Greenberg S.G., and Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87 (1990) 5827-5831
36. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. a component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
37. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (t) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83 (1986) 4913-4917
38. Hansen L.A., Armstrong D.M., and Terry R.D. An immunohistochemical quantification of fibrous astrocytes in aging human cerebral cortex. Neurobiol. Aging 8 (1987) 1-6
39. He Y., Delaere P., Duyckaerts C., Wasowicz M., Piette F., and Hauw J.J. Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: relationship with the intellectual status in 29 cases. Acta Neuropathol. 86 (1993) 109-116
40. Higgins L.S., Murphy Jr. G.M., Forno L.S., Catalano R., and Cordell B. P3 β-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimerís disease brain. Am. J. Pathol. 149 (1996) 585-596
41. Ikeda S.-I., Allsop D., and Glenner G.G. Morphology and distribution of plaque and related deposits in the brains of Alzheimeris disease and control cases: an immunohistochemical study using amyloid β-protein antibody. Lab. Invest. 60 (1989) 113-122
42. Iqbal K., and Grundke-Iqbal I. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Molec. Neurobiol. 5 (1991) 399-410
43. Ishii T., Kametani F., Haga S., and Satoh M. Subsequences of amyloid precursor protein in Alzheimer brain. In: Iqbal K., Wisniewski H.M., and Winblad B. (Eds). Alzheimer's Disease and Related Disorders (1989), A.R. Liss, New York 965-970
44. Itagaki S., McGeer P.L., Akiyama H., Zhu S., and Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24 (1989) 173-182
45. Iwatsubo T., Mann D.M., Odaka A., Suzuki N., and Ihara Y. Amyloid beta protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37 (1995) 294-299
46. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13 (1994) 45-53
47. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
48. Katzman R., and Terry R.D. Normal aging of the nervous system. In: Katzman R., and Rowe J.W. (Eds). Principles of Geriatric Neurology (1992), F.A. Davis, Philadelphia 18-58
49. Katzman R., Terry R.D., DeTeresa R., Brown T., Davies P., Fuld P., Reinbing X., and Peck A. Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23 (1988) 138-144
50. Kosik K.S., Orecchio L.D., Binder L., Trojanowski J.Q., Lee V.M., and Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1 (1988) 817-825
51. Le Prince G., Delaere P., Fages C., Duyckaerts C., Hauw J.J., and Tardy M. Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type. Neurosci. Lett. 151 (1993) 71-73
52. Ledesma M.D., Bonay P., Colaco C., and Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269 (1994) 21614-21619
53. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., and Berraan J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150 (1993) 2659-2667
54. Lee V.M., Balin B.J., Otvos Jr. L., and Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251 (1991) 675-678
55. Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T.C., and Selkoe D.J. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3 (1996) 16-32
56. Li Y.M., Dickson D.W., and Vlassara H. Enhanced binding of advanced glycation endproducts (AGE) by apo E4 isotype links mechanisms of plaque deposition in Alzheimer's disease. FASEB J. 10 (1996) A677
57. Liu W., Shafit-Zagardo B., Aquino D., Zhao M.-L., Dickson D.W., Brosnan C.F., and Lee S.C. Cytoskeletal alterations in human fetal astrocytes induced by IL-1β. J. Neurochem. 63 (1994) 1625-1634
58. Mackenzie I.R., Hao C., and Munoz D.G. Role of microglia in senile plaque formation. Neurobiol. Aging 16 (1995) 797-804
59. Mann D.M.A., Brown A.M.T., Prinja D., Jones D., and Davies C.A. A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical techniques. Neuropathol. Appl. Neurobiol. 16 (1990) 17-25
60. Mann D.M.A., Iwatsubo T., Ihara Y., Cairns N.J., Lantos P.L., Bogdanovic N., Lannfeldt L., Winblad B., Maat-Schieman M.L.C., and Rossor M.N. Predominant deposition of amyloid-β 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutation in the amyloid precursor protein gene. Am. J. Pathol. 148 (1996) 1257-1266
61. Markesbery W.R., Wang H.Z., Kowall N.W., Kosik K.S., and McKee A.C. Morphometric image analysis of neuropil threads in Alzheimer's disease. Neurobiol. Aging 14 (1993) 303-307
62. Mattiace L.A., Davies P., and Dickson D.W. Detection of HLA-DR in human microglia is dependent on clinical and technical factors. Am. J. Pathol. 136 (1990) 1101-1114
63. McGeer P.L., and McGeer E.G. The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21 (1995) 195-218
64. McKee A., Kosik K., and Kowall N.W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30 (1991) 156-165
65. Meda L., Cassatella M.A., Szendrei G.I., Otvos Jr. L., Baron P., Villalba M., Ferrari D., and Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374 (1995) 647-650
66. Morris J.C., Storandt M., McKeel Jr. D.W., Rubin E.H., Price J.L., Grant E.A., and Berg L. Cerebral amyloid deposition and diffuse plaques in normal aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46 (1996) 707-719
67. Mukaetova-Ladinska E.B., Harrington C.R., Hills R., O'Sullivan A., Roth M., and Wischik CM. Regional distribution of paired helical filaments and normal tau proteins in aging and in Alzheimer's disease with and without occipital lobe involvement. Dementia 3 (1992) 61-69
68. Munoz D.G. Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. Lab. Invest. 64 (1991) 826-832
69. Murphy Jr. G.M., Forno L.S., Higgins L., Scardina J.M., Eng L.F., and Cordell B. Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1--42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am. J. Pathol. 144 (1994) 1082-1088
70. Nalbantoglu J., Gilfix B.M., Bertrand P., Robitaille Y., Gauthier S., Rosenblatt D.S., and Poirier J. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann. Neurol. 36 (1994) 889-895
71. Nitsch R.M., Rebeck G.W., Deng M., Richardson U.I., Tennis M., Schenk D.B., Vigo-Pelfrey C., Lieberburg I., Wurtman R.J., Hyman B.T., and Growdon J.H. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Ann. Neurol. 37 (1994) 512-518
72. Olichney J.M., Hansen L.A., Galasko D., Saitoh T., Hofstetter C.R., Katzman R., and Thal L.J. The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47 (1996) 190-196
73. Paresce D.M., Ghosh R.N., and Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer disease amyloid-β-protein via a scavenger receptor. Neuron 17 (1996) 553-565
74. Perry V.H., Matyszak M.K., and Fearn S. Altered antigen expression of microglia in the aged rodent CNS. GLIA 7 (1993) 60-67
75. Peters A., Rosene D.L., Moss T.L., Kemper C.R., Abraham C.R., Tigges J., and Albert M.S. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J. Neuropathol. Exp. Neurol. 55 (1996) 861-874
76. Pike C.J., Cummings B.J., and Cotman C.W. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp. Neurol. 132 (1995) 172-179
77. Pollanen M.S., Markiewicz P., and Goh C. Paired helical filaments are twisted ribbons composed of two parallel and aligned components: Image reconstruction and modeling of filament structure using atomic force microscopy. J. Neuropathol. Exp. Neurol. 56 (1997) 79-85
78. Price J.L., Davis P.B., Morris J.C., and White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 12 (1991) 295-312
79. Probst A., Anderton B.H., Brion J.-P., and Ulrich J. Senile plaque neurites fail to demonstrate anti-paired helical filament and anti-microtubule-associated protein-tau immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex. Acta Neuropathol. 77 (1989) 430-436
80. Rebeck G.W., Perls T.T., West H.L., Sodhi P., Lipsitz L.A., and Hyman B.T. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old. Neurology 44 (1994) 1513-1516
81. Rees S. A quantitative electron microscopic study of the aging human cerebral cortex. Acta Neuropathol. 36 (1976) 347-362
82. Rogers J., Luber-Narod J., Styren S.D., and Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9 (1988) 339-349
83. Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J., Gowing E., and Ball M.J. β-Amyloid-(1--42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90 (1993) 10836-10840
84. Rozemuller J.M., Eikelenboom P., Stam F.C., Beyreuther K., and Masters C.L. A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol. 48 (1989) 674-691
85. Salthouse T.A. The processing-speed theory of adult age differences in cognition. Psychol. Rev. 103 (1996) 428-430
86. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., and Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
87. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., and Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90 (1993) 9649-9653
88. Schmidt M.L., DiDario A.G., Lee V.M., and Trojanowski J.Q. An extensive network of PHF-tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer's disease. FEBS Lett. 344 (1994) 69-73
89. Selkoe D.J., Yamazaki T., Citron M., Podlisny M.B., Koo E.H., Teplow D.B., and Haass C. The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Ann. N.Y. Acad. Sci. 777 (1996) 57-64
90. Shin R.-W., Ogomori K., Kitamoto T., and Tateishi J. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease. Am. J. Pathol. 134 (1989) 1365-1371
91. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.-D., Stern D., Sayre L.M., Monnier V.M., and Perry G. Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91 (1994) 5710-5714
92. Sohal R.S., and Brunk U.T. Lipofuscin as an indicator of oxidative stress and aging. Adv. Exp. Med. Biol. 266 (1989) 17-26
93. Sparks D.L., Scheff S.W., Liu H., Landers TR., Danner F., Coyne C.M., and Hunsaker III J.C. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients. J. Neurol. Sci. 138 (1995) 97-104
94. Stadtman E.R. Protein oxidation and aging. Science 257 (1992) 1220-1224
95. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90 (1993) 1977-1981
96. Styren S.D., Civin W.H., and Rogers J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp. Neurol. 110 (1990) 93-104
97. Troncoso J.C., Martin L.J., Dal Forno G., and Kawas C.H. Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging. Neurobiol. Aging 17 (1996) 365-371
98. Uchihara T., Duyckaerts C., Lazarini F., He Y., Kobayashi K., Seilhean D., and Hauw J.J. Inconstant apolipoprotein E (apoE)-like immunoreactivity in amyloid (protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease. Acta Neuropathol. 92 (1996) 180-185
99. Vermersch P., Frigard B., David J.-D., Fallet-Bianco C., and Delacourte A. Presence of abnormally phosphorylated tau proteins in the entorhinal cortex of aged non-demented subjects. Neurosci. Lett. 144 (1992) 143-146
100. Vlassara H., Brownlee M., Manogue K.R., Dinarello C., and Pasagian A. Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling. Science 240 (1988) 1546-1548
101. Vlassara H., Bucala R., and Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70 (1994) 138-151
102. Walsh D.A. Age differences in central perceptual processing: a dichoptic backward masking investigation. J. Gerontol. 31 (1976) 178-185
103. Wang D., and Munoz D.G. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. J. Neuropathol. Exp. Neurol. 54 (1995) 548-556
104. Wille H., Drewes G., Biernat J., Mandelkow E.M., and Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell Biol. 118 (1992) 573-584
105. Wisniewski H.M., Bancher C., Barcikowska M., Wen G.Y., and Currie J. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. 78 (1989) 337-347
106. Wisniewski H.M., Narang H.K., and Terry R.D. Neurofibrillary tangles of paired helical filaments. J. Neurol. Sci. 27 (1976) 173-181
107. Wisniewski H.M., Vorbrodt A.W., Wegiel J., Morys J., and Lossinskyi A.S. Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie. Am. J. Med. Genetics Suppl. 7 (1992) 287-290
108. Yamaguchi H., Hirai S., Morimatsu M., Shoji M., and Ihara Y. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by b protein immunostaining. Acta Neuropathol. 76 (1988) 541-549 1988
109. Yamaguchi H., Ishiguro K., Sugihara S., Nakazato Y., Kawarabayashi T., Sun X., and Hirai S. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Acta Neuropathol. 88 (1994) 413-419
110. Yan S.-D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stem D., and Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
111. Yan S.-D., Chen X., Schmid A.-M., Brett J., Godman G., Zou Y.-S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.-H., and Stern D. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91 (1994) 7787-7791
112. Yen S.-H., Dickson D.W., Crowe A., Butler M., and Shelanski M.L. Alzheimer neurofibrillary tangles contain unique epitopes and epitopes in common with heat-stable microtubule-associated proteins, MAP2 and tau. Am. J. Pathol. 126 (1987) 63-73
113. Yen S.-H., Liu W.-K., Hall F.L., Yan S.-D., Stern D., and Dickson D.W. Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components. Neurobiol. Aging 16 (1995) 381-387
114. Younkin S.G. Processing of the Alzheimer's disease beta A4 amyloid protein precursor (APP). Brain Pathol. 1 (1991) 253-262